We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform capable of autonomously evolving solutions for cancer treatment. 

EVO-NANO brings together expertise in computer science, artificial evolution, modelling, microfluidics, and medicine.

We are a cross-disciplinary team working across Europe to produce targeted nanoparticles for the treatment of cancer tumours. Our scientists come from the University of Bristol and University of West of England, both in UK, University of Novi Sad, Serbia, Åbo Akademi University, Finland, IMDEA Software Institute, Vall d’Hebron Research Institute (VHIR), both in Spain, and ProChimia Surfaces in Poland.

Dec 23, appears to no longer exist. Website was https://evonano.eu/